State Street’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.5M Buy
4,526,937
+52,734
+1% +$739K ﹤0.01% 1557
2025
Q1
$70M Sell
4,474,203
-476,522
-10% -$7.45M ﹤0.01% 1468
2024
Q4
$69M Sell
4,950,725
-690,906
-12% -$9.62M ﹤0.01% 1554
2024
Q3
$52.5M Buy
5,641,631
+506,788
+10% +$4.71M ﹤0.01% 1687
2024
Q2
$47.8M Sell
5,134,843
-3,649,195
-42% -$33.9M ﹤0.01% 1702
2024
Q1
$87M Buy
8,784,038
+7,258,993
+476% +$71.9M ﹤0.01% 1400
2023
Q4
$4.93M Sell
1,525,045
-2,835,762
-65% -$9.16M ﹤0.01% 2950
2023
Q3
$23.2M Sell
4,360,807
-865,202
-17% -$4.59M ﹤0.01% 2078
2023
Q2
$49.8M Buy
5,226,009
+1,611,228
+45% +$15.4M ﹤0.01% 1683
2023
Q1
$39.8M Sell
3,614,781
-64,604
-2% -$711K ﹤0.01% 1801
2022
Q4
$54.5M Buy
3,679,385
+1,024,150
+39% +$15.2M ﹤0.01% 1571
2022
Q3
$50.7M Buy
2,655,235
+1,258,810
+90% +$24.1M ﹤0.01% 1591
2022
Q2
$29.8M Buy
1,396,425
+206,925
+17% +$4.41M ﹤0.01% 1966
2022
Q1
$22.9M Buy
1,189,500
+69,194
+6% +$1.33M ﹤0.01% 2295
2021
Q4
$23.2M Buy
1,120,306
+81,093
+8% +$1.68M ﹤0.01% 2373
2021
Q3
$24.8M Sell
1,039,213
-113,269
-10% -$2.71M ﹤0.01% 2330
2021
Q2
$31.5M Buy
1,152,482
+184,500
+19% +$5.03M ﹤0.01% 2194
2021
Q1
$28M Buy
967,982
+128,960
+15% +$3.73M ﹤0.01% 2142
2020
Q4
$23.6M Buy
839,022
+573,588
+216% +$16.1M ﹤0.01% 2141
2020
Q3
$7.78M Buy
265,434
+78,854
+42% +$2.31M ﹤0.01% 2573
2020
Q2
$5.64M Buy
186,580
+19,022
+11% +$575K ﹤0.01% 2698
2020
Q1
$4.99M Buy
+167,558
New +$4.99M ﹤0.01% 2629